Eltrombopag in the treatment of immune thrombocytopenia secondary to SLE: A double-edged sword.

Beltagy A, Abdelati A, Fayed F, Eshak N, Elghandour A, Elbahoty MH

Open source

DOI
10.1177/09612033261506749
Published
2026 Nov 10
Container
Lupus
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1177/09612033261506749,
  title = {Eltrombopag in the treatment of immune thrombocytopenia secondary to SLE: A double-edged sword.},
  author = {Beltagy A and Abdelati A and Fayed F and Eshak N and Elghandour A and Elbahoty MH},
  year = {2026},
  journal = {Lupus},
  doi = {10.1177/09612033261506749},
  url = {https://doi.org/10.1177/09612033261506749}
}

RIS

TY  - JOUR
TI  - Eltrombopag in the treatment of immune thrombocytopenia secondary to SLE: A double-edged sword.
AU  - Beltagy A
AU  - Abdelati A
AU  - Fayed F
AU  - Eshak N
AU  - Elghandour A
AU  - Elbahoty MH
PY  - 2026
JO  - Lupus
DO  - 10.1177/09612033261506749
UR  - https://doi.org/10.1177/09612033261506749
ER  - 

APA

A, B., A, A., F, F., N, E., A, E., & MH, E. (2026). Eltrombopag in the treatment of immune thrombocytopenia secondary to SLE: A double-edged sword.. Lupus. https://doi.org/10.1177/09612033261506749

Source records